Regulating surgical oncotaxis to improve the outcomes in cancer patients

Surgery Today

Volumn 44, Issue 5, 2014, Pages 804-811

  Hirai, Toshihiro ^a   Matsumoto, Hideo ^a   Kubota, Hisako ^a   Yamaguchi, Yoshiyuki ^a  

^a KAWASAKI MEDICAL SCHOOL   (Japan)

Author keywords

Active oxygen; Omega 3 fatty acid; Oncotaxis; Surgery

Indexed keywords

CORTICOSTEROID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; OMEGA 3 FATTY ACID; REACTIVE OXYGEN METABOLITE; SCAVENGER;

BLOOD CLOTTING DISORDER; CANCER PATIENT; CANCER SURGERY; CORTICOSTEROID RELEASE; CYTOKINE RELEASE; HUMAN; IMMUNE DEFICIENCY; LOW DRUG DOSE; METASTASIS; MINIMALLY INVASIVE SURGERY; OUTCOME ASSESSMENT; PERIOPERATIVE PERIOD; POSTOPERATIVE COMPLICATION; REVIEW; SURGICAL ONCOTAXIS; SURGICAL STRESS;

ADRENAL CORTEX HORMONES; CYTOKINES; FATTY ACIDS, OMEGA-3; FREE RADICAL SCAVENGERS; HUMANS; IMMUNE SYSTEM; NEOPLASM METASTASIS; NEOPLASMS; NF-KAPPA B; PERIOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS; REACTIVE OXYGEN SPECIES; STRESS, PHYSIOLOGICAL; SURGICAL PROCEDURES, MINIMALLY INVASIVE; THROMBOSIS; TREATMENT OUTCOME;

EID: 84899990944     PISSN: 09411291     EISSN: 14362813     Source Type: Journal    
DOI: 10.1007/s00595-013-0627-0     Document Type: Review

References (84)

1. Hattori T, Hamai Y, Ikeda H, Harada T, Ikeda T. Enhancing effect of thoracotomy on tumor growth in rats. Gann. 1978;69:401-6. (Pubitemid 8368021)
2. Hattori T, Hamai Y, Takiyama W, Hirai T, Ikeda T. Enhancing effect of thoracotomy on tumor growth in rats with special reference to the duration and timing of the operation. Gann. 1980;71:280-4. (Pubitemid 10086770)
3. Hirai T, Matsumoto H, Yamashita Y, Urakami A, Iki K, Yamamura M, et al. Surgical oncotaxis-excessive surgical stress and postoperative complications contribute to enhancing tumor metastasis, resulting in a poor prognosis for cancer patients. Ann Thorac Cardiovasc Surg. 2005;11:4-6.
4. Albert D, Zeidman I. Relation of glucocorticoid activity of steroids to number of metastases. Cancer Res. 1962;22:1297-300.
5. Zeidman I. The fate of circulating tumor cells. A mechanism of cortisone action in increasing metastases. Cancer Res. 1962;22:501-3.
6. Kodama M, Kodama T. Enhancing effect of hydrocortisone on hematogenous metastasis of Ehrlich ascites tumor in mice. Cancer Res. 1975;35:1015-21.
7. Hirai T. Experimental studies on tumor enhancing effect of operative stress with special reference to the participation of corticosteroid (in Japanese). Hiroshimadaigaku Igaku Zasshi (Med J Hiroshima Univ). 1985;33:871-82.
8. Glasner A, Avraham R, Rosenne E, Benish M, Zmora O, Shemer S, et al. Improving survival rates in two models of spontaneous postoperative metastasis in mice by combined administration of a beta-adrenergic antagonist and a cyclooxygenase-2 inhibitor. J Immunol. 2010;184:2449-57.
9. Kakkar AK, Lorenzo F, Pineo GF, Williamson RCN. Venous thromboembolism and cancer. Bailliere's Clin Haematol. 1998;11:675-87. (Pubitemid 29119142)
10. Stouthard JML, Levi M, Hack CE, Veenhof CHN, Romijn HA, Sauerwein HP, et al. Interleukin-6 stimulates coagulation, not fibrinolysis, in humans. Thromb Haemost. 1996;76:738-42. (Pubitemid 26388179)
11. Nawroth PP, Stern DM. Tumor necrosis factor/cachectin-induced modulation of endothelial cell hemostatic properties. Onkologie. 1987;10(254):258.
12. Suemasu K, Ishikawa S. Inhibitive effect of heparin and dextran sulfate on experimental pulmonary metastases. Gann. 1970;61:125-30.
13. Rak J, Milsom C, May L, Klement P, Yu J. Tissue factor in cancer and angiogenesis: the molecular link between genetic tumor progression, tumor neovascularization, and cancer coagulopathy. Semin Thromb Hemost. 2006;32:54-7.
14. Kakkar AK, Lemoine NR, Scully MF, Tebbutt S, Williamson RC. Tissue factor expression correlate with histological grade in human pancreatic cancer. Br J Surg. 1995;82:1101-4.
15. Nakasaki T, Wada H, Shigemori C, Miki C, Gabazza EC, Mobori T, et al. Expression of tissue factor and vascular endothelial growth factor is associated with angiogenesis in colorectal cancer. Am J Hematol. 2002;69:247-54. (Pubitemid 34259846)
16. Sawada M, Miyake S, Ohdama S, Mstsubara O, Masuda S, Yakumaru K, et al. Expression of tissue factor in non-small-cell lung cancers and its relationship to metastasis. Br J Cancer. 1999;79:472-7. (Pubitemid 29046221)
17. Poon RT, Lau CP, Ho JW, Yu WC, Fan ST, Wong J. Tissue factor expression correlates with tumor angiogenesis and invasiveness in human hepatocellular carcinoma. Clin Cancer Res. 2003;9:5339-45. (Pubitemid 37413589)
18. Takagi T, Sakakura C, Kin S, Nakase Y, Fukuda K, Shimomura K, et al. Dextran sulfate suppresses cell adhesion and cell cycle progression of melanoma cells. Anticancer Res. 2005;25:895-902. (Pubitemid 40546860)
19. DeFeo K, Hayes C, Chernick M, Ryn JV, Gilmour SK. Use of dabigastran etexilate to reduce breast cancer progression. Cancer Biol Ther. 2010;10:1001-8.
20. Dolovich LR, Ginsberg JS, Douketis JD, Holbrook AM, Cheah G. A meta-analysis comparing low-molecular-weight heparin with unfractioned heparin in the treatment of venous thromboembolism. Arch Intern Med. 2000;160:181-8.
21. Altinbas M, Coskun HS, Er O, Ozkan M, Eser B, Unal A, et al. A randomized clinical trial of combination chemotherapy with and without low-molecular-weight heparin in small cell lung cancer. J Thromb Haemost. 2004;2:1266-71. (Pubitemid 40186120)
22. Kakkar AK, Levine MN, Kadziola Z, Lemoine NR, Low V, Patel HK, et al. Low molecular weight heparin, therapy with dalteparin, and survival in advanced cancer: the fragmin advanced malignancy outcome study (FAMOUS). J Clin Oncol. 2004;22:1944-8. (Pubitemid 41095187)
23. Kirstein JM, Graham KC, Mackenzie LT, Johnston DE, Martin LJ, Tuck AB, et al. Effect of anti-fibrinolytic therapy on experimental melanoma metastasis. Clin Exp Metastasis. 2009;26:121-31.
24. Nadir Y, Brenner B. Heparanase procoagulant activity. Thromb Res. 2012;129:576-9.
25. Ogawa K, Hirai M, Katsube T, Murayama M, Hamaguchi K, Shimakawa T, et al. Suppression of cellular immunity by surgical stress. Surgery. 2000;127:329-36. (Pubitemid 30140632)
26. Vallina VL, Velasco JM. The influence of laparoscopy on lymphocyte subpopulations in the surgical patient. Surg Endosc. 1996;10:481-4. (Pubitemid 126467580)
27. Shafirb M, Bekesi JG, Papatestas A, Slater G, Aufses AH Jr. Preoperative and postoperative immunological evaluation of patients with colorectal cancer. Cancer. 1980;46:700-5. (Pubitemid 10034446)
28. Cristaldi M, Rovati M, Elli M, Gerlinzani S, Lesma A, Barzarotti L, et al. Lymphocyte subpopulation changes after open and laparoscopic cholecystectomy: a prospective and comparative study on 38 patients. Surg Laparosc Endosc. 1997;7:255-61.
29. Leaver HA, Craig SR, Yap PL, Walker WS. Lymphocyte responses following open and minimally invasive thoracic surgery. Eur J Clin Invest. 2000;30:230-8. (Pubitemid 30153664)
30. Ben-Eliyohu S, Page GG, Yirmaiya R, Shakhar G. Evidence that stress and surgical interventions promote tumor development by suppressing natural killer cell activity. Int J Cancer. 1999;80:880-8. (Pubitemid 29108864)
31. Ahlers O, Nachtigall I, Lenze J, Goldmann A, Schulte E, Hohne C, et al. Intraoperative thoracic epidural anesthesia attenuates stress-induced immunosuppression in patients undergoing major abdominal surgery. Br J Anaesth. 2008;101:781-7.
32. Mafdy AM, Galley HF, Abdel-Wahed MA, el-Korny KF, Sheta SA, Webster NR. Differential modulation of interleukin-6 and inter-leukin-10 by diclofenac in patients undergoing major surgery. Br J Anaesth. 2002;88:797-802. (Pubitemid 34618955)
33. Dithmar S, Rusciano D, Lynn MJ, Lawson DH, Armstrong CA, Grossniklaus HE. Neoadjuvant interferone alfa-2b treatment in a murine model for metastatic ocular melanoma: a preliminary study. Arch Ophthalmol. 2000;118:1085-9. (Pubitemid 30643341)
34. Gallagher WJ, Dubinett SM, Hoover HC Jr, Kradin RL. Efficacy of adjuvant interleukin-2 after excision of BALB/c fibrosarcoma. Surgery. 1989;106:120-5. (Pubitemid 19236449)
35. Caprotti R, Bribio F, Fumagalli L, Nobili C, Degrate L, Lissoni P, et al. Free-from-progression period and overall short preoperative immunotherapy with IL-2 increases the survival of pancreatic cancer patients treated with macroscopically radical surgery. Anticancer Res. 2008;28:1951-4. (Pubitemid 351892912)
36. Bravio F, Lissoni P, Fumagalli L, Girlando M, Marsili MT, Nespoli A, et al. Pre-operative IL-2 immunoprophylaxis of cancer recurrence: long term clinical results of a phase II study in radically operable colorectal cancer. Oncol Rep. 1999;6:1205-7.
37. Toge T, Hirai T, Takiyama W, Hattori T. Effects of surgical stress on natural killer activity, proliferative response of spleen cells and cytostatic activity of lung macrophages in rats. Gann. 1981;72:790-4. (Pubitemid 12239924)
38. Hattori T, Hamai Y, Ikeda T, Takiyama W, Hirai T, Miyoshi Y. Inhibitory effects of immunopotentiators on the enhancement of lung metastases induced by operative stress in rats. Gann. 1982;73:132-5. (Pubitemid 12100993)
39. Yamaguchi Y, Hihara J, Hironaka K, Ohshita A, Okita R, Okawaki M, et al. Postoperative immunosuppression cascade and immunotherapy using lymphokine-activated killer cells for patients with esophageal cancer: possible application for compensatory anti-inflammatory response syndrome. Oncol Rep. 2006;15:895-901.
40. Adamson IYR, Young L, Orr FW. Tumor metastasis after hyperoxic injury and repair of the pulmonary endothelium. Lab Invest. 1987;57:71-7. (Pubitemid 17101246)
41. Nonaka Y, Iwagaki H, Kimura T, Fuchimoto S, Orita K. Effect of reactive oxygen intermediates on the in vitro invasive capacity of tumor cells and liver metastasis in mice. Int J Cancer. 1993;54:983-6. (Pubitemid 23267473)
42. ten Kate M, van der Wal JB, Sluiter W, Hofland LJ, Jeekel J, Sonneveld P. The role of superoxide anions in the development of distant tumour recurrence. Br J Cancer. 2006;95:1497-503. (Pubitemid 44863352)
43. Mongaret C, Alexandre J, Thomas-Schoemann A, Bermudez E, Cherau C, Nicco C, et al. Tumor invasion induced by oxidative stress is dependent on membrane ADAM 9 protein and its secreted form. Int J Cancer. 2011;129:791-8.
44. Hirai T, Yoshimoto A, Iwata T, Yamashita Y, Kuwahara M, Toge T. Enhancing effect of thoraco-laparotomy on liver metastasis and the role played by active oxygen in its mechanism. Jpn J Surg. 1997;27:1040-5. (Pubitemid 27491832)
45. Hyoudou K, Nishikawa M, Kobayashi Y, Ikemura M, Yamashita F, Hashida M. SOD derivatives prevent metastatic tumor growth aggravated by tumor removal. Clin Exp Metastasis. 2008;25:531-6.
46. Sun Y-F, Yang X-R, Zhou J, Qiu S-J, Fan J, Xu Y. Circulating tumor cells: advances in detection methods, biological issues, and clinical relevance. J Cancer Res Clin Oncol. 2011;137:1151-73.
47. Rahbari NN, Aigner M, Thorlund K, Mollberg N, Motschall E, Jensen K, et al. Meta-analysis shows that detection of circulating tumor cells indicates poor prognosis in patients with colorectal cancer. Gastroenterology. 2010;138:1714-26.
48. Qu Y, Wang J, Ray PS, Guo H, Huang J, Shin-Shim M, et al. Thioredoxin-like 2 regulates human cancer cell growth and metastasis via redox homeostasis and NF-kB signaling. J Clin Invest. 2011;121:212-25.
49. Tsukioka T, Nishiyama N, Iwata T, Nagano K, Tei K, Suehiro S. Preoperative serum oxidative stress marker as a strong indicator of nodal involvement in clinical stage I lung adenocarcinoma. Int J Clin Oncol. 2012;17:250-5.
50. Brokelman WJ, Lansvert M, Borel Rinkes IH, Kinkenbijil JH, Reijinen MM. Peritoneal change due to laparoscopic surgery. Surg Endosc. 2011;25:1-9.
51. Ishikawa M, Nishioka M, Hanaki N, Miyauchi T, Kashiwagi Y, Ioki H, et al. Perioperative immune response in cancer patients undergoing digestive surgeries. World J Surg Oncol. 2009;7:7.
52. Brune IB, Wilke W, Hensler T, Feussner H, Holzmann B, Siewert JR, et al. Normal T lymphocyte and monocyte function after minimally invasive surgery. Surg Endosc. 1998;12:1020-4. (Pubitemid 128531424)
53. Kloosterman T, von Blomberg BM, Borgstein P, Cuesta MA, Scheper RJ, Meijer S. Unimpaired immune functions after laparoscopic cholecystectomy. Surgery. 2006;139:39-45.
54. Vittimberga FJ Jr, Foley DP, Meyers WC, Callery MP. Laparoscopic surgery and the systemic immune response. Ann Surg. 1998;227:326-34. (Pubitemid 28131012)
55. Eisold S, Mehrabi A, Konstantinidis L, Mieth M, Hinz U, Kashfi A, et al. Experimental study of cardiorespiratory and stress factors in esophageal surgery using robot-assisted thoracoscopic or open thoracic approach. Arch Surg. 2008;143:156-63. (Pubitemid 351281619)
56. Amin AT, Shiraishi N, Ninomiya S, Tajima M, Inomata M, Kitano S. Increased mRNA expression of epidermal growth factor receptor, human epidermal receptor, and survivin in human gastric cancer after the surgical stress of laparotomy versus carbon dioxide pneumoperitoneum in a murine model. Surg Endosc. 2010;24:1427-33.
57. Tsujimoto H, Takahata R, Nomura S, Yaguchi Y, Kumano I, Matsumoto Y, et al. Video-assisted thoracoscopic surgery for esophageal cancer attenuates postoperative systemic responses and pulmonary complications. Surgery. 2012;151:667-73.
58. Walker WS, Leaver HA. Immunologic and stress responses following video-assisted thoracic surgery and open pulmonary lobectomy in early stage lung cancer. Thorac Surg Clin. 2007;17:241-9. (Pubitemid 46862951)
59. Biere SS, van Berge Henegouwen MI, Maas KW, Bonavina L, Rosman C, Garcia JR, et al. Minimally invasive versus open oesophagectomy for patients with oesophageal cancer: a multicentre, open-label, randomized controlled trial. Lancet. 2012;379:1887-92.
60. Rizk NP, Bach PB, Schrag D, Bains MS, Turnbull AD, Karpeh M, et al. The impact of complications on outcomes after resection for esophageal and gastroesophageal junction carcinoma. J Am Coll Surg. 2004;198:42-50. (Pubitemid 38201087)
61. Hu Y, Zheng B, Rong T-H, Fu J-H, Zhu Z-H, Yang H, et al. Prognostic analysis of the patients with stage-III esophageal squamous cell carcinoma after radical esophagectomy. Chin J Cancer. 2010;29:178-83.
62. Shimada H, Okazumi S, Matsubara H, Nabeya Y, Shiratori T, Hayashi H, et al. Is the surgical stress associated with worse survival in patients with esophageal cancer?-analysis of colon substitution for 37 patients with remnant stomach. Hepatogastroenterology. 2007;54:791-5. (Pubitemid 46903725)
63. Sierzega M, Kolodziejczyk P, Kulig J. Impact of anastomotic leakage on long-term survival after total gastrectomy for carcinoma of the stomach. Br J Surg. 2010;97:1035-42.
64. Toshihiro H, Hihara J, Inoue H, Toge T, Inoue Y, Sakaue T. The effect of radical scavenger EPC-K1 and methylprednisolone on reactive substances after surgery (in Japanese). Nippon Syoukakigekagakkaishi (Jpn J Gastroenterol Surg). 2001;34:323-8. (Pubitemid 32377875)
65. Sayama J, Shineha R, Yokota K, Hirayama K, Higuchi N, Ohe H, et al. Control of the excessive reaction after surgery for esophageal carcinoma with preoperative administration of the corticosteroids (in Japanese). Nippon Syoukakigekagakkaishi (Jpn J Gastroenterol Surg). 1994;27:841-8.
66. Ueda H, Hirakawa H, Shineha R, Sayama J, Nishihira T, Mori S. Postoperative changes of serum IL-6 production and preventive effects of methylprednisolone for mouse experimental surgical stress (in Japanese). Nippon Syoukakigekagakkaishi (Jpn J Gastroenterol Surg). 1994;27:2191.
67. Raimondi AM, Guimaraes HP, Amaral JLG, Leal PHR. Perioperative glucocorticoid administration for prevention of systemic organ failure in patients undergoing esophageal resection for esophageal carcinoma. Sao Paulo Med J. 2006;124:112-5. (Pubitemid 44194365)
68. Shimada H, Ochiai T, Okazumi S, Matsubara H, Nabeya Y, Miyazawa Y, et al. Clinical benefits of steroid therapy on surgical stress in patients with esophageal cancer. Surgery. 2000;128:791-8.
69. Shimada H, Okazumi S, Matsubara H, Nabeya Y, Hayashi H, Shiratori T, et al. Effects of steroid therapy on postoperative course and survival of patients with thoracic esophageal carcinoma. Esophagus. 2004;1:89-94.
70. Nishizaki C, Nishikawa M, Yata T, Yamada T, Takahashi Y, Oku M, et al. Inhibition of surgical trauma-enhanced peritoneal dissemination of tumor cells by human catalase derivatives in mice. Free Radic Biol Med. 2011;51:773-9.
71. By Ho, Wu YM, Chang KJ, Pan TM. Dimerumic acid inhibits SW620 cell invasion by attenuating H2O2-mediated MMP-7 expression via JNK/C-Jun and ERK/C-Fos activation in an AP-1-dependent manner. Int J Biol Sci. 2011;7:869-80.
72. O'Leary DP, Bhatt L, Woolley JF, Gough DR, Wang JH, Cotter TG, et al. TLR-4 signalling accelerates colon cancer cell adhesion via NF-kB mediated transcriptional up-regulation of Nos-1. PLoS ONE. 2012;7:e44176.
73. Yuksel M, Okajima K, Uchiba M, Okabe H. Gabexate mesilate, a synthetic protease inhibitor, inhibits lipopolysaccharide-induced tumor necrosis factor-alpha production by inhibiting activation of both nuclear factor-kappaB and activator protein-1 in human monocytes. J Pharmacol Exp Ther. 2003;305:298-305. (Pubitemid 36373864)
74. Ohashi I, Nishijima J, Murata A, Tada H, Kato H. Inhibitory effect of a synthetic protease inhibitor (gabexate mesilate) on the respiratory burst oxidase in human neutrophils. J Biochem. 1995;118:1001-6.
75. Jung SE, Yun IJ, Youn YK, Lee JE, Ha J, Noh DY, et al. Effect of protease inhibitor on ischemia-reperfusion injury to rat liver. World J Surg. 1999;23:1027-31. (Pubitemid 29451720)
76. Goldfarb Y, Shapiro H, Singer P, Kalderon Y, Levi B, Glasner A, et al. Fish oil attenuates surgery-induced immunosuppression, limits post-operative metastatic dissemination and increases long-term recurrence-free survival in rodents inoculated with cancer cells. Clin Nutr. 2012;31:396-404.
77. Kontogiannea M, Gupta A, Ntanios F, Graham T, Jones P, Meterissian S. Omega-3 fatty acids decrease endothelial adhesion of human colorectal carcinoma cells. J Surg Res. 2000;92:201-5. (Pubitemid 30612631)
78. Gutt CN, Brinkmann L, Mehrabi A, Fonouni H, Muller-Stich BP, Vetter G, et al. Dietary omega-3-polyunsaturated fatty acids prevent the development of metastasis of colon carcinoma in rat liver. Eur J Nutr. 2007;46:279-85. (Pubitemid 47125268)
79. Prasad S, Ravindran J, Aggarwal BB. NF-j B and cancer: how intimate is this relationship. Mol Cell Biochem. 2010;336:25-37.
80. Ghosh-Choudhury T, Mandal CC, Woodruff K, Clair PS, Fernandes G, Choudhury GG, et al. Fish oil targets PTEN to regulate NFκB for downregulation of anti-apoptotic genes in breast tumor growth. Breast Cancer Res Treat. 2009;118:213-8.
81. Zhao Y, Joshi-Barve S, Barve S, Chen LH. Eicosapentaenoic acid prevents LPS-induced TNF-α expression by preventing NF-κB activation. J Am Coll Nutr. 2004;23:71-8. (Pubitemid 38200837)
82. Mishra A, Chaudhary A, Sethi S. Oxidized omega-3 fatty acids inhibit NF-κB activation via a PPARα-dependent pathway. Arterioscler Thromb Vasc Biol. 2004;24:1621-7. (Pubitemid 39180885)
83. Jho DH, Cole SM, Lee EM, Espat NJ. Role of omega-3 fatty acid supplementation in inflammation and malignancy. Integr Cancer Ther. 2004;3:98-111. (Pubitemid 38669043)
84. Wang J, Yu JC, Kang WM, Ma ZQ. Superiority of a fish oilenriched emulsion to medium-chain triacylglycerols/long-chain triacylglycerols in gastrointestinal surgery patients: a randomized clinical trial. Nutrition. 2012;28:623-9.